vs

Side-by-side financial comparison of Ambiq Micro, Inc. (AMBQ) and CuriosityStream Inc. (CURI). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $18.2M, roughly 1.1× Ambiq Micro, Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -49.6%, a 29.8% gap on every dollar of revenue.

Ambiq Micro, Inc. is an American semiconductor company specializing in low-power microcontrollers and systems-on-chip, including products for devices smartwatches, medical devices, and sensors. Founded in 2010 by University of Michigan researchers Scott Hanson, David Blaauw, and Dennis Sylvester, the company is headquartered in Austin, Texas. Its products employ Subthreshold Power Optimized Technology (SPOT) to reduce energy consumption and enable on-device edge AI. In 2025, Ambiq went public...

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

AMBQ vs CURI — Head-to-Head

Bigger by revenue
CURI
CURI
1.1× larger
CURI
$19.2M
$18.2M
AMBQ
Higher net margin
CURI
CURI
29.8% more per $
CURI
-19.7%
-49.6%
AMBQ

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
AMBQ
AMBQ
CURI
CURI
Revenue
$18.2M
$19.2M
Net Profit
$-9.0M
$-3.8M
Gross Margin
42.3%
Operating Margin
-55.3%
-17.6%
Net Margin
-49.6%
-19.7%
Revenue YoY
35.8%
Net Profit YoY
-34.6%
EPS (diluted)
$-0.72
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMBQ
AMBQ
CURI
CURI
Q4 25
$19.2M
Q3 25
$18.2M
$18.4M
Q2 25
$17.9M
$19.0M
Q1 25
$15.1M
Q4 24
$14.1M
Q3 24
$12.6M
Q2 24
$12.4M
Q1 24
$12.0M
Net Profit
AMBQ
AMBQ
CURI
CURI
Q4 25
$-3.8M
Q3 25
$-9.0M
$-3.7M
Q2 25
$-8.5M
$784.0K
Q1 25
$319.0K
Q4 24
$-2.8M
Q3 24
$-3.1M
Q2 24
$-2.0M
Q1 24
$-5.0M
Gross Margin
AMBQ
AMBQ
CURI
CURI
Q4 25
Q3 25
42.3%
Q2 25
40.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
AMBQ
AMBQ
CURI
CURI
Q4 25
-17.6%
Q3 25
-55.3%
-24.5%
Q2 25
-49.2%
2.5%
Q1 25
0.5%
Q4 24
-27.4%
Q3 24
-25.8%
Q2 24
-20.6%
Q1 24
-30.4%
Net Margin
AMBQ
AMBQ
CURI
CURI
Q4 25
-19.7%
Q3 25
-49.6%
-20.4%
Q2 25
-47.5%
4.1%
Q1 25
2.1%
Q4 24
-19.9%
Q3 24
-24.3%
Q2 24
-16.4%
Q1 24
-42.0%
EPS (diluted)
AMBQ
AMBQ
CURI
CURI
Q4 25
$-0.07
Q3 25
$-0.72
$-0.06
Q2 25
$-18.89
$0.01
Q1 25
$0.01
Q4 24
$-0.05
Q3 24
$-0.06
Q2 24
$-0.04
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMBQ
AMBQ
CURI
CURI
Cash + ST InvestmentsLiquidity on hand
$146.5M
$27.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$169.8M
$41.5M
Total Assets
$186.7M
$75.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMBQ
AMBQ
CURI
CURI
Q4 25
$27.3M
Q3 25
$146.5M
$27.8M
Q2 25
$47.5M
$28.1M
Q1 25
$33.4M
Q4 24
$32.1M
Q3 24
$33.2M
Q2 24
$39.5M
Q1 24
$38.8M
Stockholders' Equity
AMBQ
AMBQ
CURI
CURI
Q4 25
$41.5M
Q3 25
$169.8M
$47.2M
Q2 25
$-307.3M
$49.8M
Q1 25
$58.1M
Q4 24
$57.8M
Q3 24
$62.2M
Q2 24
$64.8M
Q1 24
$67.0M
Total Assets
AMBQ
AMBQ
CURI
CURI
Q4 25
$75.7M
Q3 25
$186.7M
$74.7M
Q2 25
$89.2M
$78.7M
Q1 25
$85.3M
Q4 24
$86.2M
Q3 24
$87.6M
Q2 24
$90.9M
Q1 24
$94.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMBQ
AMBQ
CURI
CURI
Operating Cash FlowLast quarter
$-5.0M
$4.0M
Free Cash FlowOCF − Capex
$3.9M
FCF MarginFCF / Revenue
20.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMBQ
AMBQ
CURI
CURI
Q4 25
$4.0M
Q3 25
$-5.0M
$4.4M
Q2 25
$-10.5M
$2.8M
Q1 25
$1.9M
Q4 24
$3.0M
Q3 24
$2.3M
Q2 24
$2.2M
Q1 24
$666.0K
Free Cash Flow
AMBQ
AMBQ
CURI
CURI
Q4 25
$3.9M
Q3 25
Q2 25
Q1 25
$1.8M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
AMBQ
AMBQ
CURI
CURI
Q4 25
20.5%
Q3 25
Q2 25
Q1 25
12.2%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
AMBQ
AMBQ
CURI
CURI
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.5%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
AMBQ
AMBQ
CURI
CURI
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMBQ
AMBQ

Customer Concentration Risk$16.2M89%
Other$2.0M11%

CURI
CURI

Segment breakdown not available.

Related Comparisons